Summary:
The 401 and 402 Studies are looking at a potential new treatment- an investigational medication- for bipolar depression (bipolar I or bipolar II disorder) to see whether it works, and how safe it is, for improving the symptoms of bipolar depression. The 401 study will look at the investigational medication when it is used on its own. The 402 Study will look at the investigational medication in patiens who are already taking a mood stabilizer, specifically litium or valproate.
Qualified Participants Must:
• Be between 18 and 75 years of age
•
Have been diagnosed with bipolar I or bipolar II disorder
•
Be currently having a major depressive episode that started at least 2 weeks ago, but no more than 6 months ago
•
Have previously had at least one bipolar manic episode or mixed episode (if you have bipolar I disorder) or hypomanic episode (if you have bipolar II disorder)
Qualified Participants May Receive:
Compensation for travel; Study medication is at no cost to participant. No insurance is required.